Seeing Is Believing
with an average price target of $19.18. This is a potential upside of $19.16 (95800%) from yesterday's end of day stock price of $0.02.
Impel Neuropharma's activity chart (see below) currently has 5 price targets and 5 ratings on display.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 40 days.
Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 15-Nov-2022. First documented stock forecast 18-May-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-May-2021
$5
$4.98 (24900.00%)
$31
3 years 4 months 18 days ago
(15-Nov-2022)
1/3 (33.33%)
$1.96 (64.47%)
80
Buy Since 03-Sep-2021
$55
3 years 4 months 19 days ago
(14-Nov-2022)
0/1 (0%)
$36.35 (194.91%)
What is IMPL (Impel Neuropharma) average time for price targets to be met?
Which analyst has the current highest performing score on IMPL (Impel Neuropharma) with a proven track record?
Which analyst has the current lower performing score on IMPL (Impel Neuropharma) with a proven track record?
Which analyst has the most public recommendations on IMPL (Impel Neuropharma)?
Which analyst is the currently most bullish on IMPL (Impel Neuropharma)?
Which analyst is the currently most reserved on IMPL (Impel Neuropharma)?